Skip to main content

Breadcrumb

  1. Home

BRAF Rearrangement

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about BRAF Rearrangement

Bladder Cancer

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about Bladder Cancer

BCL6/MYC t(3;8)

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about BCL6/MYC t(3;8)

BCL2 (18q21)

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about BCL2 (18q21)

BCL6 (3q27)

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about BCL6 (3q27)

CCND1(BCL1)/IgH t(11;14)

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about CCND1(BCL1)/IgH t(11;14)

BCR/ABL1/ASS1 t(9;22)

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about BCR/ABL1/ASS1 t(9;22)

BIRC3(API2)/MALT1 t(11;18)

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about BIRC3(API2)/MALT1 t(11;18)

AML Standard FISH Panel

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about AML Standard FISH Panel

AML Favorable-Risk Panel

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about AML Favorable-Risk Panel

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • Page 32
  • …
  • Next page Next
  • Last page Last
Subscribe to